查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198541

手术导航系统市场-增长、趋势、COVID-19 影响和预测 (2023-2028)

Surgical Navigation Systems Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 111 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

手术导航系统市场预计在预测期内的复合年增长率为 6.32%。

COVID-19 大流行对手术导航系统市场产生了重大影响，对择期手术的区域限制导致一些手术被推迟。 此外，在 COVID-19 期间手术数量减少，阻碍了市场增长。 根据英国外科杂誌 2020 年报告，在 COVID-19 期间，约有 2800 万次择期手术被取消或推迟。 患者更愿意等待看医生，这影响了手术导航系统市场。 根据 2020 年 6 月发表的研究论文《COVID-19 对印度普通外科实践的影响》，印度封锁后的每日门诊人数每天减少 4 人，约 77%。专家表示，他们没有进行过一次手术手术。 另一方面，其他因素，例如对更好的患者治疗效果和临床试验结果的需求，也可能推动新技术在导航辅助手术中的采用，并支持长期的市场增长。

手术导航系统是计算机辅助手术不可或缺的一部分。 它代表了一种支持基于数字成像技术的外科手术的概念。 这使得外科医生能够进行术前规划，并在手术过程中对器械进行精确的手术导航。 骨关节炎、脑肿瘤和耳鼻喉科等目标疾病的患病率上升，以及人口老龄化加剧，可能是增长的驱动力。 根据 E-Clinical Medicine 2020 发表的一篇论文，膝骨关节炎 (OA) 的患病率在 15 岁及以上人群中为 16%，在 40 岁及以上人群中患病率为 22.9%。15 岁以上人群患病率为 20%年龄和 20% 的人超过 40 岁。 2020 年，全球约有 6.54 亿人（40 岁及以上）患有膝关节炎。 对于 20 岁及以上的人，发病率为每 10,000 人年 203 例。 手术导航系统用于绘製患者膝盖的地图，以便更好地理解和有效地进行手术。 因此，预计对这项技术的需求会增加。

其他因素，例如对微创手术的需求不断增长和技术进步，预计也将推动该市场的增长。 然而，手术导航系统价格昂贵，可能不会被一些医院采用。

手术导航系统市场趋势

心臟手术有望占据较大的市场份额

心臟手术或心血管手术是由心臟外科医生对心臟和大血管进行的手术。 在过去的几年里，技术在全球范围内取得了长足的进步，手术导航系统在心血管手术中得到了广泛应用。 心血管疾病发病率的增加和先进技术的可用性预计将推动这一领域的增长。

根据世界卫生组织 (WHO) 2021 年 6 月的统计数据，2019 年估计有 1790 万人死于心血管疾病，占全球所有死亡人数的 32%。 这些死亡中有 85% 是由于心脏病发作或中风。 据同一消息来源称，2019 年有 1700 万人（70 岁以下）过早死于非传染性疾病，其中心血管疾病占 38%。 因此，由于死亡率增加，心臟手术有望出现增长，从而推动该领域的增长。

然而，增加对心血管疾病治疗的资助也有望促进创新和研究，从而促进市场增长。 根据美国国立卫生研究院 2020，预计 2022 年心血管疾病的投资预计为 26.22 亿美元。 这比 2021 年的 24.99 亿美元有了显着增长。

产品发布、战略合作伙伴关係和联合协议预计将在预测期内推动这一细分市场。 例如，2020 年 11 月，雅培 (Abbott) 的新 EnSite X EP 系统在澳大利亚获得了 CE 标誌和批准，并将在欧洲和澳大利亚推出该系统。 EnSite X 系统是唯一提供两种不同选项的系统，可在一个平台上导航心肌解剖结构。

北美有望主导手术导航系统市场

北美在全球手术导航系统市场占据主导地位，这主要是因为其成熟的医疗保健和医疗设备行业。 这种市场增长主要是由于手术导航系统市场上存在主要参与者。

在北美进行的手术数量不断增加是市场增长的主要推动力。 例如，2021 年 1 月发表的一项题为“COVID-19 大流行对罗马尼亚东北部三级护理中心胃肠内窥镜检查活动的影响”的研究发现，在 2019 年 COVID 之前，共有 3608 例内窥镜检查进行了大约每週 138 次手术。 这导致手术数量的增加，增加了对手术导航系统的需求并推动了市场的增长。

由于免疫系统减弱，老年人更容易患上慢性病。 根据《2019年世界老龄化报告》，2019年美国65岁及以上人口有5334万人，预计到2050年这一数字将达到8481.3万人。 老年人口的这种预期增加可能会增加慢性病的发病率，从而促进手术导航系统在诊断和治疗中的使用。

亚太地区预计在预测期内增长最快，这主要是由于医疗行业越来越多地采用技术进步。

手术导航系统市场竞争者分析

世界主要参与者开发了大部分手术导航系统。 拥有更多研究资金和更好的分销系统的市场领导者正在市场中站稳脚跟。 此外，由于意识的提高，亚太地区出现了一些较小的参与者，这有助于市场增长。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 慢性病的发病率和患病率增加
    • 丰富应用的技术进步
  • 市场製约因素
    • 手术导航系统成本高
    • 严格的产品审批规定
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按技术
    • 电磁感应法
    • 混合导航系统
    • 光学导航系统
    • 荧光 X 射线导航
    • CT导航
    • 其他技术
  • 通过申请
    • 神经外科
    • 骨科
    • 耳鼻喉手术
    • 心臟外科
    • 其他应用
  • 最终用户
    • 医院
    • 门诊
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Brainlab AG
    • B Braun Melsungen AG
    • Fiagon AG
    • Karl Storz
    • Medtronic PLC
    • Siemens AG
    • Stryker Corporation（Scopis Gmbh）
    • Zimmer Biomet Holdings
    • Cascination AG
    • DePuy Synthes

第7章 市场机会今后动向

简介目录
Product Code: 67241

The surgical Navigation Systems Market is poised to witness a CAGR of 6.32% during the forecast period.

The COVID-19 pandemic has significantly impacted the surgical navigation system market, with regional restrictions on elective procedures causing several procedures to be delayed. Moreover, the number of surgeries declined during COVID-19, hampering the market growth. According to a British Journal of Surgery report 2020, approximately 28 million elective surgeries were canceled or postponed during COVID-19. Patients preferred to wait for hospital visits, which impacted the surgical navigation system market. According to the research article 'Impact of COVID-19 on General Surgical Practice in India,' published in June 2020, post-lockdown daily out-patient visits reduced to 4 patients/day in India, and approximately 77% of professionals did not perform even a single surgical procedure. ​​On the other hand, other factors, such as the demand for better patient outcomes and the results of clinical trials, are likely to drive the adoption of new technologies in navigation-assisted surgeries and support long-term market growth.

Surgical navigation systems are an integral part of computer-assisted surgery. This represents a concept that supports surgical procedures based on digital imaging technology. It allows surgeons pre-operative planning and accurate surgical navigation of instruments during the process. The growth is likely to be fueled by the rising prevalence of target conditions such as osteoarthritis, brain tumors, ENT disorders, and the growing senior population. According to the article published in the E-Clinical Medicine 2020, for people aged 15 and up, the prevalence of knee osteoarthritis (OA) was 16%, while in people aged 40 and above, the prevalence was 22.9%. In 2020, roughly 654 million people worldwide (40 years and older) had knee OA. In people aged 20 and above, the global incidence of knee OA was 203 per 10,000 person-years. Surgical navigation systems map the knee of the patient to understand it better and carry out efficient surgical operations. Hence, the demand for this technology is expected to increase.

Other factors like growing demand for minimally invasive procedures and technological advancements are also expected to drive the growth of this market. However, the high cost of surgical navigation systems may restrain some hospitals from adopting them.

Surgical Navigation Systems Market Trends

Cardiac Surgery Expected to have a Large Market Share

Cardiac surgery, or cardiovascular surgery, is surgery on the heart or great vessels performed by cardiac surgeons. The surgical navigation system is becoming more popular in cardiovascular surgery as technology has advanced significantly over the last few years worldwide. Factors such as the increasing occurrence of cardiovascular disorders and the availability of advanced technologies are expected to boost the segment's growth.

According to World Health Organization (WHO) Statistics for June 2021, an estimated 17.9 million people died from cardiovascular diseases in 2019, accounting for 32% of all global deaths. A heart attack or a stroke caused 85% of these deaths. According to the same source, non-communicable diseases were responsible for 17 million premature deaths (under 70) in 2019, with cardiovascular diseases accounting for 38% of these deaths. ​Hence, cardiac surgery is expected to witness growth due to the increased mortality rate, driving the segment growth.

However, the rise in funding for the treatment of cardiovascular disorders is also expected to boost innovation and research, leading to market growth. According to the National Institutes of Health 2020, the estimated investment for cardiovascular diseases was expected to be USD 2,622 million in 2022. This was a significant increase from the 2021 figures of USD 2,499 million.

The product launches, strategic partnerships, and collaborative agreements are expected to drive the segment over the forecast period. For instance, in November 2020, Abbott received CE Mark and approval in Australia for its new EnSite X EP System and is launching the system throughout Europe and Australia. The EnSite X System is the only system that offers the option to navigate the cardiac anatomy two different ways on one platform.

North America Expected to Dominate the Surgical Navigation Systems Market

North America dominates the global surgical navigation systems market, majorly attributed to the well-established healthcare and medical device industry. The market's growth is majorly due to the presence of key companies operating in the surgical navigation systems market.

The increase in the number of surgeries performed in North America is the major driving factor for market growth. For instance, as per the research study published in January 2021, titled "The Impact of the COVID-19 Pandemic on Gastrointestinal Endoscopy Activity in a Tertiary Care Center from Northeastern Romania", in 2019, during the pre-COVID time, a total of 3,608 endoscopic procedures were performed, which was about 138 procedures per week.​ This increases the number of surgeries, rising the demand for a surgical navigation system and driving the market growth.

The geriatric population is more prone to chronic diseases due to the weak immune system. According to World Ageing Report 2019, the United States had 53.340 million people aged 65 years and above in 2019, and this number is expected to reach 84.813 million by 2050. This expected increase in the elderly population is likely to increase the incidence rate of chronic diseases, thus driving the use of surgical navigation systems in diagnosis and treatment.

The Asia-Pacific region is believed to witness the fastest growth over the forecast period, mainly attributed to the increasing adoption of technological advancements in the healthcare industry.

Surgical Navigation Systems Market Competitor Analysis

The global key players are developing the majority of the surgical navigation systems. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness, which has helped the market grow.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Defination
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence and Prevalence of Chronic Disorders
    • 4.2.2 Technological Advancements Leading to Enhanced Applications
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Surgical Navigation Systems
    • 4.3.2 Stringent Regulations for Product Approval
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Technology
    • 5.1.1 Electromagnetic Navigation Systems
    • 5.1.2 Hybrid Navigation Systems
    • 5.1.3 Optical Navigation Systems
    • 5.1.4 Fluoroscopy-based Navigation Systems
    • 5.1.5 CT-based Navigation Systems
    • 5.1.6 Other Technologies
  • 5.2 By Application
    • 5.2.1 Neurosurgery
    • 5.2.2 Orthopedic Surgery
    • 5.2.3 ENT Surgery
    • 5.2.4 Cardiac Surgery
    • 5.2.5 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Settings
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Brainlab AG
    • 6.1.2 B Braun Melsungen AG
    • 6.1.3 Fiagon AG
    • 6.1.4 Karl Storz
    • 6.1.5 Medtronic PLC
    • 6.1.6 Siemens AG
    • 6.1.7 Stryker Corporation (Scopis Gmbh)
    • 6.1.8 Zimmer Biomet Holdings
    • 6.1.9 Cascination AG
    • 6.1.10 DePuy Synthes

7 MARKET OPPORTUNITIES AND FUTURE TRENDS